Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection.

Antimicrobial Agents and Chemotherapy
Marie-Claude Georges-CourbotVincent Deubel

Abstract

Clinical nonrandomized trials demonstrate some efficacy for ribavirin in the treatment of patients with severe Nipah virus-induced encephalitis. We report here that EICAR, the 5-ethynyl analogue of ribavirin, and the OMP-decarboxylase inhibitors 6-aza-uridine and pyrazofurin have strong antiviral activity against Nipah virus replication in vitro. Ribavirin and 6-aza-uridine were tested further in hamsters infected with a lethal dose of Nipah virus. The activity of these small-molecule inhibitors was compared with that of the interferon inducer poly(I)-poly(C(12)U). Both ribavirin and 6-aza-uridine were able to delay but not prevent Nipah virus-induced mortality. Poly(I)-poly(C(12)U), at 3 mg/kg of body weight daily from the day of infection to 10 days postinfection, prevented mortality in 5 of 6 infected animals.

References

Apr 1, 1991·Antimicrobial Agents and Chemotherapy·E De ClercqA Matsuda
Jan 2, 1986·The New England Journal of Medicine·J B McCormickR Belmont-Williams
Dec 1, 1982·Antiviral Research·P G CanonicoW L Pannier
Jun 19, 1995·The Medical Journal of Australia·L A SelveyJ W Sheridan
Aug 19, 1995·Lancet·S P Fisher-HochJ B McCormick
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·Y HondaH Suzuki
Jul 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K A ThompsonW A Carter
Sep 29, 1999·Veterinary Microbiology·K HalpinJ S Mackenzie
May 4, 2001·Microbes and Infection·L WangB T Eaton
Jun 1, 2001·Emerging Infectious Diseases·J M YobT Ksiazek
Jun 21, 2001·Annals of Neurology·H T ChongS K Lam
Mar 7, 2002·Microbes and Infection·Kaw Bing ChuaSai Kit Lam
Jul 12, 2002·Annals of Neurology·Chong Tin TanMohd Rani Jusoh
Aug 27, 2002·Emerging Infectious Diseases·James G OlsonThomas G Ksiazek
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Pieter LeyssenJohan Neyts
May 14, 2003·Journal of Virology·Christina M UlaneCurt M Horvath
Oct 28, 2003·The American Journal of Pathology·K Thong WongVincent Deubel
Dec 25, 2003·Journal of Virology·V GuillaumeT F Wild
Jun 10, 2004·Antiviral Chemistry & Chemotherapy·John D MorreyRobert W Sidwell
Jul 29, 2004·Current Pharmaceutical Design·A PicardiA Afeltra
Aug 4, 2004·Journal of Virological Methods·Vanessa GuillaumeVincent Deubel
Jul 19, 2005·Emerging Infectious Diseases·Jean-Marc ReynesJean-Louis Sarthou

❮ Previous
Next ❯

Citations

Sep 3, 2013·Veterinary Microbiology·Emma L Croser, Glenn A Marsh
Feb 25, 2011·Expert Reviews in Molecular Medicine·Hector C Aguilar, Benhur Lee
Feb 19, 2008·The Journal of Infectious Diseases·Zhao-Hong LiShun-Hua Chen
Oct 24, 2012·The Journal of Infectious Diseases·Kévin P DhondtBranka Horvat
Dec 20, 2011·PLoS Neglected Tropical Diseases·Emmie de WitVincent J Munster
Feb 2, 2010·Emerging Infectious Diseases·Elliott G PlayfordHume Field
Mar 29, 2013·Future Microbiology·Briony HazeltonDominic E Dwyer
Jun 7, 2012·Archives of Virology·Joseph PrescottVincent J Munster
Jan 31, 2015·Expert Review of Anti-infective Therapy·Cyrille Mathieu, Branka Horvat
Aug 16, 2015·Brain Pathology·Kien Chai Ong, Kum Thong Wong
Apr 10, 2012·Current Opinion in Virology·Christopher C Broder
Oct 4, 2011·Virus Research·Thomas G KsiazekPierre E Rollin
Dec 17, 2008·The Veterinary Journal·Hana M WeingartlMarkus Czub
Oct 7, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Michael K Lo, Paul A Rota
Mar 4, 2008·Antiviral Research·Pieter LeyssenJohan Neyts
Nov 23, 2007·Antiviral Research·Michael R Holbrook, Brian B Gowen
Jul 17, 2007·Comparative Immunology, Microbiology and Infectious Diseases·Kim Halpin, Bruce A Mungall
Nov 6, 2009·The Journal of General Virology·Alexander N FreibergMichael R Holbrook
Jun 25, 2015·Nature Communications·Benjamin A SatterfieldChad E Mire
Apr 1, 2014·Antiviral Research·Michael K LoChristina F Spiropoulou
Jul 11, 2013·Antiviral Research·Christopher C BroderLin-Fa Wang
Aug 5, 2010·Veterinary Pathology·M M Williamson, F J Torres-Velez
Jan 1, 2013·Pathogens·Kévin P Dhondt, Branka Horvat
Apr 4, 2012·Viruses·Deborah L SteffenChristopher C Broder
Mar 10, 2018·PLoS Neglected Tropical Diseases·Stephen R WelchCésar G Albariño
May 6, 2016·Journal of Virology·Benjamin A SatterfieldChad E Mire
Sep 7, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Rui TangShi-You Chen
Mar 1, 2019·BMJ Global Health·Laura T Mazzola, Cassandra Kelly-Cirino
Oct 22, 2019·Frontiers in Immunology·Jinxin MiaoYaohe Wang
May 17, 2018·Scientific Reports·Brian E DawesAlexander N Freiberg
Mar 15, 2019·Epidemiology and Infection· Aditi, M Shariff
Feb 25, 2020·Database : the Journal of Biological Databases and Curation·Amit Kumar GuptaManoj Kumar
Mar 19, 2019·Intractable & Rare Diseases Research·Sayantan BanerjeeNaveet Wig
Feb 28, 2019·Frontiers in Pharmacology·Akanksha RajputManoj Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.